Recent Updates
Recently added Catalysts
Specialist biotech fund · SEC 13F

Iron Triangle Partners 13F Holdings (Q4 2025)

According to its SEC 13F filed on Feb 17, 2026, Iron Triangle Partners reported 27 long positions worth $875M as of Dec 31, 2025. CRL is 8.7% of the portfolio and the top 10 holdings are 53%. Against Q3 2025 it opened 16 new positions, added to 8, trimmed 3 and exited 14. 5 holdings have a dated FDA decision or data readout in the next 90 days, and 4 more expect one in a stated window such as "H2 2026".

Data as of Dec 31, 2025SEC 13F filed Feb 17, 2026Next filing (Q3 2026) due Nov 16, 2026Value as filed; options at underlying sharesLong positions only
Market Value$ 874.68 M13F value, as filed
QoQ Changes24.37 %13F value vs the previous quarter
Holdings27 27 stocks · 0 option positions
PeriodQ2 202613F reporting quarter
Holdings in Top 20 % top 10: 53% of the portfolio
Activity vs Q3 202516 new8 added · 3 trimmed · 14 exits
Catalysts ahead5dated in 90 days · +4 in a stated window

Holdings

Every position in the 13F, with the change since the fund's previous filing, how many of the 45 specialist funds also own it, and its next FDA catalyst. Option positions are labelled CALL or PUT.

Showing 6 Stocks Out Of 27. Click On The Tickers For More Details
Stock Company Name Shares Held Market Value % of Portfolio QoQ Change Position Change Also Held By Stage Next Catalyst
BKD
BKD
BROOKDALE SR LIVING INC
3.49 M
37.68 M
4.3
Added +23%
—
None in 90 days
NVST
NVST
ENVISTA HOLDINGS CORPORATION
1.19 M
25.76 M
2.9
New
Commercial
None in 90 days
BHVN
BHVN
BIOHAVEN LTD
958.34 K
10.82 M
1.2
New
Clinical
Oct 23, 2026
Phase 1 data readout
BTSG
BTSG
BRIGHTSPRING HEALTH SVCS INC
897.43 K
33.61 M
3.8
Trimmed -28%
—
None in 90 days
JAZZ
JAZZ
JAZZ PHARMACEUTICALS PLC
292.17 K
49.67 M
5.7
Added +95%
Commercial
Expected Q4 2026
Phase 3 data presentation
DNTH
DNTH
DIANTHUS THERAPEUTICS INC
230.73 K
9.51 M
1.1
New
Clinical
Expected 2H 2026
Phase 2 topline data readout

Top 20 Holdings

Size = share of the portfolio. Option positions show CALL or PUT.

Who else owns these stocks?

All Stock Holdings ranks every biotech stock by how many of the 45 specialist funds own it, and whether that number rose or fell this quarter. Click "of 45 funds" on any row above, or open the full view.

Open All Stock Holdings ›

Questions about Iron Triangle Partners's 13F

What does Iron Triangle Partners own?

27 stocks worth $875M at Dec 31, 2025, as reported in its 13F, led by CRL (8.7% of the portfolio). The full list is in the Holdings table above.

What did it buy and sell last quarter?

Against Q3 2025: 16 new positions, 8 increases, 3 reductions and 14 full exits, from its 13F filings.

How current is this data?

13F filings are due 45 days after each quarter ends, so they show positions at quarter end, not today. The next filing (Q3 2026) is due Nov 16, 2026.

Why are some positions labelled CALL or PUT?

Those are option positions (calls and puts). The 13F reports them as the shares underlying the option, with no strike or expiry, so they are listed apart from share positions.

Source: SEC EDGAR Form 13F-HR filed by IRON TRIANGLE PARTNERS LP, accession 0001172661-26-000928, filed Feb 17, 2026. Values as filed; option positions are shown at the value of the underlying shares and labelled CALL or PUT.